vs
Side-by-side financial comparison of BillionToOne, Inc. (BLLN) and Voyager Technologies, Inc. (VOYG). Click either name above to swap in a different company.
BillionToOne, Inc. is the larger business by last-quarter revenue ($83.5M vs $46.7M, roughly 1.8× Voyager Technologies, Inc.). BillionToOne, Inc. runs the higher net margin — 6.8% vs -70.7%, a 77.6% gap on every dollar of revenue. On growth, BillionToOne, Inc. posted the faster year-over-year revenue change (117.4% vs 23.7%). BillionToOne, Inc. produced more free cash flow last quarter ($6.5M vs $-54.5M).
BillionToOne, Inc. is a life sciences and molecular diagnostics firm developing high-precision genetic testing solutions. Its core offerings include non-invasive prenatal tests, oncology diagnostics, and rare disease screening, serving clinical providers and patients mainly in North America.
BLLN vs VOYG — Head-to-Head
Income Statement — Q3 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $83.5M | $46.7M |
| Net Profit | $5.7M | $-33.0M |
| Gross Margin | 69.9% | 21.4% |
| Operating Margin | 11.5% | — |
| Net Margin | 6.8% | -70.7% |
| Revenue YoY | 117.4% | 23.7% |
| Net Profit YoY | 138.3% | -71.2% |
| EPS (diluted) | $0.10 | $-0.52 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | — | $46.7M | ||
| Q3 25 | $83.5M | $39.6M | ||
| Q2 25 | — | $45.7M | ||
| Q3 24 | $38.4M | — |
| Q4 25 | — | $-33.0M | ||
| Q3 25 | $5.7M | $-16.3M | ||
| Q2 25 | — | $-31.4M | ||
| Q3 24 | $-14.9M | — |
| Q4 25 | — | 21.4% | ||
| Q3 25 | 69.9% | 15.4% | ||
| Q2 25 | — | 18.0% | ||
| Q3 24 | 52.6% | — |
| Q4 25 | — | — | ||
| Q3 25 | 11.5% | -60.7% | ||
| Q2 25 | — | -52.8% | ||
| Q3 24 | -32.9% | — |
| Q4 25 | — | -70.7% | ||
| Q3 25 | 6.8% | -41.1% | ||
| Q2 25 | — | -68.7% | ||
| Q3 24 | -38.8% | — |
| Q4 25 | — | $-0.52 | ||
| Q3 25 | $0.10 | $-0.28 | ||
| Q2 25 | — | $-1.23 | ||
| Q3 24 | $-1.47 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $195.2M | $491.3M |
| Total DebtLower is stronger | $55.0M | — |
| Stockholders' EquityBook value | $-239.5M | — |
| Total Assets | $327.5M | — |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $491.3M | ||
| Q3 25 | $195.2M | $413.3M | ||
| Q2 25 | — | $468.9M | ||
| Q3 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | $55.0M | — | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | $-239.5M | $590.9M | ||
| Q2 25 | — | $554.7M | ||
| Q3 24 | $-242.9M | — |
| Q4 25 | — | — | ||
| Q3 25 | $327.5M | $727.8M | ||
| Q2 25 | — | $685.3M | ||
| Q3 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $13.8M | $-60.9M |
| Free Cash FlowOCF − Capex | $6.5M | $-54.5M |
| FCF MarginFCF / Revenue | 7.7% | -116.9% |
| Capex IntensityCapex / Revenue | 8.8% | — |
| Cash ConversionOCF / Net Profit | 2.42× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $-60.9M | ||
| Q3 25 | $13.8M | $-15.1M | ||
| Q2 25 | — | $-30.9M | ||
| Q3 24 | — | — |
| Q4 25 | — | $-54.5M | ||
| Q3 25 | $6.5M | $-53.8M | ||
| Q2 25 | — | $-88.8M | ||
| Q3 24 | — | — |
| Q4 25 | — | -116.9% | ||
| Q3 25 | 7.7% | -135.8% | ||
| Q2 25 | — | -194.4% | ||
| Q3 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 8.8% | 97.8% | ||
| Q2 25 | — | 126.7% | ||
| Q3 24 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 2.42× | — | ||
| Q2 25 | — | — | ||
| Q3 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BLLN
| Prenatal | $74.1M | 89% |
| Oncology | $8.7M | 10% |
VOYG
| Defense and National Security | $35.7M | 77% |
| Space Solutions | $12.5M | 27% |
